Previous close | 0.0200 |
Open | 0.0200 |
Bid | 0.0000 |
Ask | 0.0200 |
Strike | 47.50 |
Expiry date | 2024-06-21 |
Day's range | 0.0200 - 0.0200 |
Contract range | N/A |
Volume | |
Open interest | 3.24k |
Pfizer (PFE) shares tick up in pre-market trading — continuing into the green after the market open — after the pharmaceutical giant raised its full-year profit outlook and topped first-quarter earnings estimates on the top and bottom lines. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Pfizer's outlook on its future product pipeline. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Market Domination Overtime anchors Julie Hyman and Josh Lipton preview the top headlines for investors for tomorrow, Wednesday, May 1, 2024. Federal Reserve officials will issue their latest interest rate policy decision coming out of their FOMC meeting tomorrow afternoon, followed by a press conference by Fed Chair Jerome Powell. On the earnings front, a slew of companies are set to release quarterly reports, including names like DoorDash (DASH), Mastercard (MA), and Qualcomm (QCOM). For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
Pfizer stock ran up to its 50-day line after the company reported better-than-expected sales and profit. Is PFE stock a buy?